Aridis Pharmaceuticals

Aridis is a privately held biopharmaceutical company dedicated to developing novel differentiated therapies for infectious diseases. The company's pipeline of novel antibacterial and antiviral drugs is derived from its proprietary technology platform, aimed at addressing the growing public health threats of viral pandemics and antimicrobial resistance (AMR) bacteria.